To examine the effects of serum calcium concentrations on PTH biosynthesis, rats were made hyper-(serum total calcium, -3.5 mM) or hypocalcemic (-1.25 mM) and steadystate levels of PTH mRNA in parathyroid cells were measured by the primer extension method using a 32P-labeled synthetic oligomer. PTH mRNA levels increased about twofold in the rats made slightly hypocalcemic by infusion of calcium-free solution and decreased slightly in those made hypercalcemic by CaCI2 infusion (120-150 gmol/h) compared with the levels present in nonfasting control rats. Infusion of calcitonin (0.5 U/h) or EGTA (90 gmol/h) with calcium-free solution increased PTH mRNA levels further (two-to sevenfold) above the levels present in animals infused with calcium-free solution alone. These changes in PTH mRNA levels were observed after 48-but not 24-h infusion, and there was an inverse correlation between PT1H mRNA levels and serum calcium concentrations. The results suggest that changes in serum calcium concentrations in the near physiological range regulate the biOsynthesis of PTH by affecting steady-state levels of PTH mRNA when hypercalcemia or hypocalcemia continues for a relatively long period.
Introduction
PTH is the principal physiological regulator of blood calcium homeostasis. Negative feedback regulation of parathyroid glandular activity by calcium is well established. Previous studies have indicated that extracellular calcium has major regulatory influences on the steps of secretion (1, 2) and intracellular degradation of PTH (3), but not on posttranslational processing (3, 4) . However, the potential physiological role ofcalcium on transcriptional and posttranscriptional steps remains to be determined (5) .
Although a few studies in vitro have shown significant and reversible suppression of PTH mRNA levels in parathyroid cells by high calcium concentrations (6) (7) (8) , the physiological relevance of this effect is not established yet. The suppressive effect of high calcium on PTH mRNA levels has been demonstrated at nonphysiologically high calcium concentrations, and the authors did not observe an increase in PTH mRNA levels at low calcium concentrations. Similar changes in PTH mRNA levels have not been reported in vivo. Therefore, we conducted the present study in the rat to examine whether changes in serum calcium concentrations within near physiological range influence PTH mRNA levels in vivo. The results clearly demonstrate that hypercalcemia decreases and hypocalcemia increases PTH mRNA levels in parathyroid cells.
Methods
Animals and in vivo manipulations. Male Wistar rats (7-8 wk old) were anesthesized by intraperitoneal injection ofhexobarbital and the femoral vein was cannulated for the purpose ofcontinuous infusion. Four to six animals were allocated to one group and infused with the following electrolyte solutions at a speed of 3 ml/h: in group A, calcium-free solution containing 20 mM NaCI, 5 mM MgCI2, 2.5 mM KCI, and 222 mM glucose; in groups B, C, and D, the same composition of solution as in group A, but containing 40 or 50 mM CaCl2 (calcium load, 120-150 Mmol/h), 0.5 U/h synthetic salmon calcitonin (Teikoku Hormone Mfg. Co., Tokyo, Japan), and 90 ,mol/h EGTA, respectively.
The amounts of CaCI2, calcitonin, and EGTA were determined according to our previous studies to induce significant changes in serum total or ionized calcium concentrations (9) (10) (11) . Infusion was started between 1:30 and 3:30 p.m. and continued for 24 or 48 h, during which period the rats fasted. At the end ofinfusion, parathyroids were excised with thyroids, and blood samples were taken from abdominal aorta under hexobarbital anesthesia. Infusion experiments were repeated at least three times for each group, always including group A as a reference. In some experiments thyro-parathyroid glands and blood samples were obtained from nonfasting rats that did not receive an infusion (group E).
Measurements of PTH mRNA and actin mRNA by the primer extension method. Total cellular RNA was extracted from parathyroid-thyroid tissue of each rat by homogenization in guanidium thiocyanate followed by CsCl centrifugation and ethanol precipitation (12) . An 
Results
Effects ofin vivo manipulations on serum calcium. As shown in Fig. 1 , serum total calcium concentrations decreased slightly but significantly from the nonfasting level (group E) after 48 h infusion of calcium-free solution (group A) and increased after 48 h infusion of CaCl2 (group B). The changes in serum calcium concentrations were less marked after 24 h infusion of the same solutions, although the difference between groups A and B was statistically significant (Fig. 1) . Infusion of calcitonin, either for 24 or 48 h, led to a significant hypocalcemia ( Fig. 1) .
Effects ofin vivo manipulations on PTH mRNA and actin mRNA. As shown in Fig. 2 , levels of PTH mRNA increased after 48 h infusion of calcium-free solution (group A) and decreased after CaCl2 infusion (group B) compared with the levels in the nonfasting state (group E). Infusion of calcitonin (group C) or EGTA (group D) for 48 h led to a further increase in PTH mRNA levels above those present in group A (Fig. 3) . These changes in PTH mRNA levels are more evident when the data are presented as PTH mRNA/actin mRNA ratios. Though actin mRNA levels varied substantially in individual samples, the PTH mRNA/actin mRNA ratios were more uniform within the same experimental group than the PTH mRNA level itself (Figs. 2 and 3 ). When the mean PTH mRNA/actin mRNA ratio was expressed as percentage of the reference group (group A) in the same set of 48 h infusion experiments, the decrease after CaC12 infusion ranged from -50 to 75%, the increase after calcitonin from 300 to 700%, and the increase after EGTA from 200 to 300% in three different sets of experiments for each protocol. Thus, there was an inverse relationship between PTH mRNA/aetin mRNA ratio and serum calcium concentration (Fig. 4) . It was unclear, however, whether the inverse relationship was a simple linear one or a sigmoidal one as established in the relationship between PTH secretion and serum calcium concentrations (2) . (14) ( 7 424) I (10) (6)T1 (15) (2, 16) . Thus, it seems reasonable to postulate that the two processes of secretion and biosynthesis are closely coupled and that sustained secretion of PTH under hypocalcemic conditions is made possible by continuous de novo synthesis of the hormone. However, this hypothesis has never been proven because earlier studies in vitro (5-7) failed to show any stimulatory effects of hypocalcemia on the levels of PTH mRNA.
The present study demonstrates for the first time that PTH mRNA levels increase when serum calcium concentrations decrease. We have also confirmed previous observations made in vitro (6) (7) (8) in a more physiological way by showing that moderate hypercalcemia induced in vivo suppresses PTH mRNA levels in parathyroid cells. These calcium-dependent changes in PTH mRNA levels are specific: we measured actin mRNA as an internal reference and found that the levels of actin mRNA did not vary with serum calcium concentrations. Simultaneous measurements of actin mRNA with PTH mRNA and calculation of PTH mRNA/actin mRNA ratio in the quantitative analyses correct for the influence of variation based on technical differences.
The inverse relationship of serum calcium concentrations with PTH mRNA levels demonstrated in the present study is similar to the relationship between calcium concentrations and PTH secretion (2) . This observation supports the concept that the processes of secretion and biosynthesis of PTH are closely coupled under physiological conditions. However, our findings do not provide conclusive evidence that serum calcium concentrations directly regulate PTH mRNA levels. There remains the possibility that in vivo manipulations and subsequent changes in serum calcium concentrations produced various metabolic changes and some of these changes affected PTH mRNA levels.
Among the potential variables, serum magnesium and phosphate concentrations had no correlation with PTH mRNA levels (data not shown). Calcitonin does not seem to be a key factor that affected PTH mRNA levels. The results of EGTA infusion experiments indicate that hypocalcemia induced by other means than calcitonin could increase PTH mRNA levels. The present findings cannot be explained by the effects of 1,25-dihydroxyvitamin D (1,25(OH)2D) .' The changes in PTH mRNA levels observed were opposite to those expected in case 1,25(OH)2D played a major regulatory role. Under hypocalcemic conditions, an increase in endogenous production of 1 ,25(OH)2D (1 1, 17 ) would contribute to a decrease in PTH mRNA levels rather than the increase shown here because 1,25(OH)2D is reported to have a suppressive effect on PTH mRNA levels (18, 19) . Under hypercalcemic conditions, the converse would be expected. It is likely therefore that serum calcium concentration per se has the most important regulatory effect on the levels of PTH mRNA in the present study, although we cannot exclude the possibility that other factors also have some effects on PTH mRNA levels. The relative importance of serum calcium and other factors such as 1,25(OH)2D, as well as their possible interactions in the regulation of PTH biosynthesis, remain to be elucidated.
The results of our study in vivo are different from those of previous studies in vitro (6) (7) (8) The mechanisms through which the changes in serum calcium concentrations affect PTH mRNA levels are unknown. Steady-state levels of PTH mRNA may be influenced by both production and degradation of PTH mRNA. In the previous in vitro studies it is demonstrated that the suppression of PTH mRNA levels by high calcium is preceded by a decrease in PTH gene transcription rate, and it is suggested that the effects of calcium at the step of transcription may be direct (8, 20) . The possibility that the changes in PTH mRNA levels might result partly from the effects ofcalcium on PTH mRNA degradation is not tested in these studies. To clarify whether similar observations are to be made in vivo and to determine what kind of intracellular events mediate the signal of changes in extracellular calcium, further studies are required.
